PGE-M as a biomarker of pulmonary inflammation

摘要

Abstract of the Disclosure The invention provides a method of, and a kit for, assessing a pulmonary abnormality in a human by providing a standard that relates a degree of pulmonary abnormality with a level of a prostaglandin E₂ metabolite, determining the level of the prostaglandin E₂ metabolite in a human, and comparing the level determined in the human to the standard whereby the pulmonary abnormality in the human is assessed.